Fact.MR Presents Key Insights on Global Ovarian Cancer Diagnostics Market Based on Product Type, End-Use and Regional Demand Till 2022
The hospital associated lab segment is expected to record a CAGR of 7.8% from 2017-2022 and rise from just under $300 million in 2017 to roughly US$ 440 million in 2022.
View full press release